Filters
Other countries
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
GUCY1A3 Gene Moyamoya type 6 with achalasia NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 23 | 30 |
|
GUCY1A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae Hereditary Moyamoya Disease Panel Invitae United States | 2 | 2 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 414 | 800 |
|
Cerebral vascular malformations (WES based NGS panel of 30 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 30 |
|
Moyamoya disease (panel NGS basado en WES de 3 genes, incluyendo análisis de CNVs) CGC Genetics Unilabs Portugal | 1 | 3 |
|
CGC Genetics Unilabs Portugal | 1 | 277 |
|
Moyamoya disease 6 with achalasia (sequence analysis of GUCY1A3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
SUDDEN DEATH/ IDIOPATHIC VENTRICULAR FIBRILLATION EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 394 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Stroke (NGS Panel and Copy Number Analysis + mtDNA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 3 | 85 |
|
GeneDx United States | 2 | 2592 |
|
GeneDx United States | 1 | 1501 |
|
Moyamoya disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 3 |
|
Fulgent Genetics United States | 1 | 1 |
|
Mental retardation - different panels Institute of Human Genetics Cologne University Germany | 7 | 2536 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.